Carroll Financial Associates’s Takeda Pharmaceutical TAK Stock Holding History

Carroll Financial Associates’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$15K	Buy	1,105 +784	+244%	+$11K	﹤0.01%	1063
2021 Q3	$5K	Hold	321	–	–	﹤0.01%	1380
2021 Q2	$5K	Hold	321	–	–	﹤0.01%	1449
2021 Q1	$5K	Hold	321	–	–	﹤0.01%	1378
2020 Q4	$5K	Hold	321	–	–	﹤0.01%	1270
2020 Q3	$5K	Hold	321	–	–	﹤0.01%	1196
2020 Q2	$5K	Hold	321	–	–	﹤0.01%	1210
2020 Q1	$4K	Hold	321	–	–	﹤0.01%	1201
2019 Q4	$6K	Hold	321	–	–	﹤0.01%	1219
2019 Q3	$5K	Hold	321	–	–	﹤0.01%	1206
2019 Q2	$5K	Buy	321 +145	+82%	+$2.64K	﹤0.01%	1216
2019 Q1	$3K	Buy	+176	New	+$3.54K	﹤0.01%	1219

Other funds holding TAK

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BCP

BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Carroll Financial Associates's TAK Position: Q4 2021 in Review

Carroll Financial Associates increased its Takeda Pharmaceutical (TAK) stake by 244% in Q4 2021, buying an estimated $11K and bringing the position to 1,105 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #1063.

Carroll Financial Associates first reported a position in TAK in Q1 2019 and has held it in 12 quarters since. 299 funds tracked by Wall St. Rank hold TAK as of Q4 2021.

Carroll Financial Associates held 1,105 shares of Takeda Pharmaceutical worth $15K as of Q4 2021.
Carroll Financial Associates bought 784 Takeda Pharmaceutical shares in Q4 2021, an estimated $11K.
Takeda Pharmaceutical made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #1063 holding.
Carroll Financial Associates first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 12 quarters since.
299 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.